Cannabis
Mike Tyson Launches His Own Cannabis Brand
In starting a cannabis brand, Tyson is not alone. A whole host of celebrities from different generations have gotten into the cannabis business. For example, Bob Marley’s family has been marketing the “Marley Natural” strain since 2016. “Tyson 2.0” is intended to help other people with emotional and physical pain. Together with distributor Columbia Care, sales of Tyson’s new variety began in Colorado.
It’s said to have made him a “different person.” Mike Tyson makes no secret of his love for cannabis. Now the former heavyweight boxing world champion is launching his own cannabis brand. “Tyson 2.0” is also intended to help other people with emotional and physical pain. Mike Tyson told CNBC cannabis makes him a “different person” and that he’s releasing his Tyson 2.0 cannabis line to help others looking for emotional and physical relief. Tyson put a Iot of work into breeding the right strain.
It’s said to have become quite complex, but Tyson is having “the best time of my life.” Together with distributor Columbia Care, sales of Tyson’s new variety began in Colorado. About $90 per ounce is said to be the cost of the product – just slightly above the local average price.
Born2Invest’s team of journalists gathers the most interesting business news in a single mobile application. It’s impossible to keep up with everything you’re interested in, but our companion app will help you keep track of the important news. Our app is being updated throughout the day.
Tyson is not the only celebrity to enter the cannabis business
The CEO of “Tyson 2.0” said that Tyson isn’t just a name – he has a sustained involvement in the research and development of the strain. Meanwhile, the boxer continues to swear by the healing and life-changing powers of hemp: “I use it for my life.” He sees himself as an unbearable person even without cannabis: “If I don’t use it for a week or three days, something of that capacity, I’m totally a different person. And I’m not a likable person”. Researching Tyson’s past, it remains doubtful that cannabis alone would have helped.
In starting a cannabis brand, Tyson is not alone. A whole host of celebrities from different generations have gotten into the cannabis business. Bob Marley’s family has been marketing the “Marley Natural” strain since 2016; rapper Jay-Z, Carlos Santana, Grateful Dead’s Mickey Hart, and even Willie Nelson did the same and started their own cannabis brands. The great diversity of these celebrities shows: whether country or hip-hop musicians; whether in their early 20s or soon to be 90 – cannabis has arrived in every stratum of the population in the USA.
Tyson was recently asked by Malawi to become the country’s “cannabis ambassador.” According to the BBC, Tyson has accepted the offer and will visit the country soon – to help market Malawi cannabis. There, the cultivation of cannabis and its medical properties were legalized in 2020.
In Germany, meanwhile, it remains unclear how cannabis will be sold after legalization. Whether at pharmacies, coffee shops, or newly licensed retailers, the brands of various celebrities and even Tyson’s “undefeated cannabis” are unlikely to be available in Germany in the near future.
__
(Featured image by Ed Webster CC BY 2.0 via Flickr)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in HanfJournal, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Africa2 weeks ago
Souss-Massa Launches ‘Back to Business’: Accelerating Investment with Bold Strategies
-
Biotech1 week ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA
-
Cannabis2 weeks ago
Ireland: Legislative Committee Calls for Legalization of Cannabis and Decriminalization of Drugs
-
Biotech5 days ago
Dijon Biotech Company Inventiva Raises 348 Million to Complete Its Phase III